[Neuralink Submits First Paper Containing Human Data] According to a report by Jinse Finance, Neuralink, the brain-computer interface company under Elon Musk, has submitted a scientific paper to an academic journal detailing trial results from some patients. This marks the company's first peer-reviewed paper containing human data. Michael Lawton, CEO and president of Barrow Neurological Institute, one of Neuralink's clinical trial sites, revealed that the paper has been submitted to *The New England Journal of Medicine*. It covers data from the first three patients implanted with Neuralink devices and includes safety data. Neuralink is one of several companies developing brain-computer interface technology, which enables direct communication between the brain and electronic devices. The company has raised over $1 billion in funding, with its valuation reaching $9 billion in the latest funding round. However, it has not yet published any peer-reviewed research containing human data. These results will allow external scientists to independently evaluate the actual effectiveness of its devices.